Mozart Therapeutics
Developer of disease-modifying therapies designed to focus on developing novel immune engagers. The company offers CD8 T-cell immune modulators for the treatment of autoimmune diseases, as it specific...
Valuation
$0
Share Price
N/A
Total Raised
$80M
Last Round
N/A